Italian	JJ	5
chemical	NN	5
giant	NN	5
Montedison	NNP	5
S.p.A.	NNP	15
,	,	7
through	IN	15
its	PRP$	13
Montedison	NNP	13
Acquisition	NNP	13
N.V.	NNP	13
indirect	JJ	13
unit	NN	7
,	,	7
began	VBD	0
its	PRP$	20
$	$	20
37-a-share	JJ	17
tender	NN	20
offer	NN	15
for	IN	20
all	DT	25
the	DT	25
common	JJ	25
shares	NNS	21
outstanding	JJ	25
of	IN	25
Erbamont	NNP	29
N.V.	NNP	32
,	,	32
a	DT	32
maker	NN	27
of	IN	32
pharmaceuticals	NNS	33
incorporated	VBN	32
in	IN	35
the	DT	38
Netherlands	NNPS	36
.	.	15

The	DT	2
offer	NN	15
,	,	2
advertised	VBN	2
in	IN	4
today	NN	7
's	POS	8
editions	NNS	5
of	IN	8
The	DT	13
Wall	NNP	13
Street	NNP	13
Journal	NNP	9
,	,	2
is	VBZ	0
scheduled	VBN	15
to	TO	18
expire	VB	16
at	IN	18
the	DT	21
end	NN	19
of	IN	21
November	NNP	22
.	.	15

Montedison	NN	3
currently	RB	3
owns	VBZ	0
about	IN	6
72	CD	4
%	NN	3
of	IN	6
Erbamont	NN	9
's	POS	11
common	JJ	11
shares	NNS	7
outstanding	JJ	11
.	.	3

The	DT	2
offer	NN	3
is	VBZ	0
being	VBG	3
launched	VBN	4
pursuant	JJ	5
to	TO	6
a	DT	11
previously	RB	11
announced	VBN	9
agreement	NN	7
between	IN	11
the	DT	14
companies	NNS	12
.	.	3
